Literature DB >> 17854430

Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments.

C Vilches1, J Castaño, N Gómez-Lozano, E Estefanía.   

Abstract

Detection of killer-cell immunoglobulin-like receptors (KIR) genes by polymerase chain reaction with sequence-specific primers (PCR-SSP) led in 1997 to the discovery that human genomes diverge largely in the KIR they encode. While only a few KIR genes are conserved in all humans, most individuals lack several those genes, which tend to associate in diverse haplotypic combinations. The PCR-SSP technique, updated to detect the more recently identified KIR genes and alleles, is still used widely to analyze the diversity of human populations, and to study the influence of KIR-gene variability on human health. Several published PCR-SSP methods for KIR genotyping, although simple and robust, have the drawback of relying on the amplification of DNA fragments spanning 0.5-2.0 kbp, which tends to fail in low-quality DNAs. Valuable collections of DNAs often include such poor quality samples, which lead to loss of data and resources. Even worse, undetected falsely negative or positive reactions may result in erroneous gene frequencies and in odd gene combinations. To address those problems, we have redesigned our previously published KIR genotyping method so that it produces short amplicons (less than 200 bp for most genes). This modification minimizes amplification failures, thus conferring greater consistency and reliability to KIR genotyping. In addition, the new PCR-SSP method detects recently described alleles of several KIR genes, and allows for discrimination between the major structural variants of KIR2DS4 and KIR3DP1 without increasing the number of reactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854430     DOI: 10.1111/j.1399-0039.2007.00923.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  72 in total

1.  Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing.

Authors:  Lihua Hou; Minghua Chen; Noriko Steiner; Kanthi Kariyawasam; Jennifer Ng; Carolyn K Hurley
Journal:  Methods Mol Biol       Date:  2012

2.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

3.  Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves' disease.

Authors:  Romina Dastmalchi; Ali Farazmand; Sina Noshad; Mohamad Mozafari; Mahdi Mahmoudi; Alireza Esteghamati; Aliakbar Amirzargar
Journal:  Mol Biol Rep       Date:  2014-05-23       Impact factor: 2.316

4.  Killer-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reaction.

Authors:  H A Hong; A S Loubser; D de Assis Rosa; V Naranbhai; W Carr; M Paximadis; D A Lewis; C T Tiemessen; C M Gray
Journal:  Tissue Antigens       Date:  2011-09

5.  Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection.

Authors:  N Yawata; K J Selva; Y-C Liu; K P Tan; A W L Lee; J Siak; W Lan; M Vania; A Arundhati; L Tong; J Li; J S Mehta; M Yawata
Journal:  Mucosal Immunol       Date:  2015-06-17       Impact factor: 7.313

6.  Licensing delineates helper and effector NK cell subsets during viral infection.

Authors:  Anthony E Zamora; Ethan G Aguilar; Can M Sungur; Lam T Khuat; Cordelia Dunai; G Raymond Lochhead; Juan Du; Claire Pomeroy; Bruce R Blazar; Dan L Longo; Jeffrey M Venstrom; Nicole Baumgarth; William J Murphy
Journal:  JCI Insight       Date:  2017-05-18

7.  Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I.

Authors:  Jeanette E Boudreau; Xiao-Rong Liu; Zeguo Zhao; Aaron Zhang; Leonard D Shultz; Dale L Greiner; Bo Dupont; Katharine C Hsu
Journal:  Immunity       Date:  2016-08-02       Impact factor: 31.745

8.  CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.

Authors:  Juan Du; Sandra Lopez-Verges; Brandelyn N Pitcher; Jeffrey Johnson; Sin-Ho Jung; Lili Zhou; Katharine Hsu; Myron S Czuczman; Bruce Cheson; Lawrence Kaplan; Lewis L Lanier; Jeffrey M Venstrom
Journal:  Cancer Immunol Res       Date:  2014-06-23       Impact factor: 11.151

9.  Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.

Authors:  Rafijul Bari; Piya Rujkijyanont; Erin Sullivan; Guolian Kang; Victoria Turner; Kwan Gan; Wing Leung
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

10.  Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2.

Authors:  Wei Wang; Amy K Erbe; Mikayla Gallenberger; KyungMann Kim; Lakeesha Carmichael; Dustin Hess; Eneida A Mendonca; Yiqiang Song; Jacquelyn A Hank; Su-Chun Cheng; Sabina Signoretti; Michael Atkins; Alexander Carlson; Jonathan M Weiss; James Mier; David Panka; David F McDermott; Paul M Sondel
Journal:  Cancer Immunol Immunother       Date:  2016-09-30       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.